Ex-DOH chief wants Dengvaxia vaccine back

ILOILO – Vaccination remains to be the most effective protection against dengue, said former Health secretary Janette Garin. She appealed for the return of the controversial Dengvaxia anti-dengue vaccine in the market.

She, however, clarified that only those with dengue or had it in the past should be vaccinated; those who never had dengue should not.

“Importante gid nga magbalik ang bakuna sa market. If the government wouldn’t like it, fine. But make it available to private doctors,” said Garin, now congresswoman of the 1st District.

The Food and Drug Administration banned Dengvaxia. Its manufacturer Sanofi Pasteur admitted that it could cause severe dengue if given to those who have not had dengue. DOH also stopped early last year its school-based mass dengue vaccination program started in 2016 when Garin was its chief.

According to Garin, Dengvaxia is recognized in the United States of America, Singapore, Malaysia, Indonesia, and Africa.

“Personal choice ko pagnagka-dengue ako, pabakunahan na. Indi bout hambalon nga kon na-dengue kana tulad, indi kana magka-dengue sa dason. Ti, paano ang next infection? Pabay-an lang nga mapatay kay wala bulong?” said Garin, a physician.

While massive cleanup drives are good to destroy the breeding places of dengue mosquitoes, she said, “ang lamok nagasaylo gihapon.”/PN


  1. The honorable Congresswoman I believe have all the good intentions in proposing the come back of the said vaccine, but let it be better studied and its’suitability established. I don’t my children and would be grand children to be included in needless and harmful experiments.


Please enter your comment!
Please enter your name here